![Interleukin-1 Receptor-Like 2: One Receptor, Three Agonists, and Many Implications | Journal of Interferon & Cytokine Research Interleukin-1 Receptor-Like 2: One Receptor, Three Agonists, and Many Implications | Journal of Interferon & Cytokine Research](https://www.liebertpub.com/cms/10.1089/jir.2021.0173/asset/images/medium/jir.2021.0173_figure4.jpg)
Interleukin-1 Receptor-Like 2: One Receptor, Three Agonists, and Many Implications | Journal of Interferon & Cytokine Research
![Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease | Circulation Research Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease | Circulation Research](https://www.ahajournals.org/cms/asset/70706774-865b-4540-921a-9d0e4de02e26/circresaha.120.315937.fig02.gif)
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease | Circulation Research
![Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717397796-gr1.jpg)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect
![Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications - eBioMedicine Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications - eBioMedicine](https://www.thelancet.com/cms/attachment/71d419d6-f3d1-456b-a5f9-e1106476d2c6/gr1_lrg.jpg)
Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications - eBioMedicine
![Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD | European Respiratory Society Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD | European Respiratory Society](https://erj.ersjournals.com/content/erj/55/2/1900563/F1.large.jpg)
Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD | European Respiratory Society
![The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities - ScienceDirect The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1568997221000483-gr1.jpg)
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities - ScienceDirect
![Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD | European Respiratory Society Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD | European Respiratory Society](https://erj.ersjournals.com/content/erj/55/2/1900563/F2.large.jpg?width=800&height=600&carousel=1)
Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD | European Respiratory Society
![Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717397796-gr3.jpg)
Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect
![Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect Interleukin-1 Beta as a Target for Atherosclerosis Therapy: Biological Basis of CANTOS and Beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109717397796-fx1.jpg)